Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 29;20(23):6029.
doi: 10.3390/ijms20236029.

Recent Advances in Mono- and Combined Stem Cell Therapies of Stroke in Animal Models and Humans

Roxana Surugiu  1 , Andrei Olaru  2 , Dirk M Hermann  3 , Daniela Glavan  4 , Bogdan Catalin  5 , Aurel Popa-Wagner  3   6
Affiliations
Review

Recent Advances in Mono- and Combined Stem Cell Therapies of Stroke in Animal Models and Humans

Roxana Surugiu et al. Int J Mol Sci. .

Abstract

Following the failure of acute neuroprotection therapies, major efforts are currently made worldwide to promote neurological recovery and brain plasticity in the subacute and post-acute phases of stroke. Currently, there is hope that stroke recovery might be promoted by cell-based therapies. The field of stem cell therapy for cerebral ischemia has made significant progress in the last five years. A variety of stem cells have been tested in animal models and humans including adipose stem cells, human umbilical cord blood-derived mesenchymal stem cells, human amnion epithelial cells, human placenta amniotic membrane-derived mesenchymal stem cells, adult human pluripotent-like olfactory stem cells, human bone marrow endothelial progenitor cells, electrically-stimulated human neuronal progenitor cells, or induced pluripotent stem cells (iPSCs) of human origin. Combination therapies in animal models include a mix of two or more therapeutic factors consisting of bone marrow stromal cells, exercise and thyroid hormones, endothelial progenitor cells overexpressing the chemokine CXCL12. Mechanisms underlying the beneficial effects of transplanted cells include the "bystander" effects, paracrine mechanisms, or extracellular vesicles-mediated restorative effects. Mitochondria transfer also appears to be a powerful strategy for regenerative processes. Studies in humans are currently limited to a small number of studies using autologous stem cells mainly aimed to assess tolerability and side-effects of human stem cells in the clinic.

Keywords: aging; cerebral ischemia; human stem cells; restorative therapies; rodent stem cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Savitz S.I., Fisher M. Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials. Ann. Neurol. 2007;61:396–402. doi: 10.1002/ana.21127. - DOI - PubMed
    1. Ginsberg M.D. Neuroprotection for ischemic stroke: Past, present and future. Neuropharmacology. 2008;55:363–389. doi: 10.1016/j.neuropharm.2007.12.007. - DOI - PMC - PubMed
    1. Lener T., Gimona M., Aigner L., Börger V., Buzas E., Camussi G., Chaput N., Chatterjee D., Court F.F., Del Portillo H.H., et al. Applying extracellular vesicles based therapeutics in clinical trials—An ISEV position paper. J. Extracell. Vesicles. 2015;4:30087. doi: 10.3402/jev.v4.30087. - DOI - PMC - PubMed
    1. Kong T., Park J.M., Jang J.H., Kim C.Y., Bae S.H., Choi Y., Jeong Y.H., Kim C., Chang S.W., Kim J., et al. Immunomodulatory effect of CD200-positive human placenta-derived stem cells in the early phase of stroke. Exp. Mol. Med. 2018;50:e425. doi: 10.1038/emm.2017.233. - DOI - PMC - PubMed
    1. Hermanto Y., Sunohara T., Faried A., Takagi Y., Takahashi J., Maki T., Miyamoto S. Transplantation of feeder-free human induced pluripotent stem cell-derived cortical neuron progenitors in adult male Wistar rats with focal brain ischemia. J. Neurosci. Res. 2018;96:863–874. doi: 10.1002/jnr.24197. - DOI - PubMed

Substances